Fish Oil Supplement With Escitalopram for Depression
Part of Mental health clinical trials.
This study tests whether adding a fish oil supplement (CreNeuroS) to the antidepressant escitalopram works better than escitalopram alone for moderate-to-severe depression. You'll take both the supplement and the medication together over the study period.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Age 18–65 years old
- Diagnosed with major depressive disorder (moderate to severe, not mild)
- Starting or recently started escitalopram (within 2 weeks of screening)
- Medically stable with no serious liver, kidney, or heart problems
- Not pregnant, not planning pregnancy during the study, and not breastfeeding
- No active suicidal thoughts, plans, or recent suicide attempts
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether adding acupuncture to escitalopram (an antidepressant) helps people with major depression feel better. It will also compare how the treatment is tolerated and whether depressive symptoms improve.
This trial tests whether escitalopram, a common antidepressant, helps people who are experiencing their first episode of depression and have never taken medication for it. It also looks at how the drug works in the brain.
This trial tests whether transplanting healthy gut bacteria (fecal microbiota) can help people with depression that does not respond well to the antidepressant escitalopram. You will first take escitalopram for 2 weeks, and if it doesn't help enough, you may receive either the real transplant or a placebo capsule.
This Phase 4 study tests an “optimized” medication approach for adults with major depressive disorder (unipolar depression) based on how you respond over time. It may help your care team choose treatments more effectively and reduce trial-and-error.
This trial tests if probiotics can help reduce symptoms of mild to moderate anxiety or depression. It is for people aged 18–60 who are not currently taking most anxiety or depression medications and who have not used them in the last 2 weeks (except for escitalopram).
This study tests which treatment sequence works best for people with anxiety conditions (generalized, social, separation) and/or panic, who also have significant depression/anxiety symptoms. It may help you find a more effective step-by-step plan and compare treatment orders.
Hear when a new Adjunct in the Treatment of Depressive Disorder trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.